[Cephalexin monohydrate in infections of the lower part of the respiratory tract].
D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use*; D003023:Cloxacillin / Q000627:therapeutic use; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007964:Leukocytosis / Q000209:etiology; D008034:Lincomycin / Q000627:therapeutic use; D008169:Lung Abscess / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009268:Nalidixic Acid / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D011014:Pneumonia / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013752:Tetracycline / Q000627:therapeutic use
D002511:Cephalosporins; D010406:Penicillins; D009268:Nalidixic Acid; D004917:Erythromycin; D000667:Ampicillin; D008034:Lincomycin; D013752:Tetracycline; D003023:Cloxacillin
Monohidrato de cefalexina en las infecciones de la porción inferior de las vias respiratorias.